Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic

  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adicet Bio Inc (NQ: ACET )

5.610 -0.010 (-0.18%)
Streaming Delayed Price Updated: 2:42 PM EDT, May 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 136,670
Open 5.640
Bid (Size) 5.610 (3)
Ask (Size) 5.630 (3)
Prev. Close 5.620
Today's Range 5.480 - 5.900
52wk Range 5.130 - 21.87
Shares Outstanding 42,957,586
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Adicet Bio's Cancer Candidate Shows Anti-Tumor Activity In Preclinical Study
Adicet Bio Inc (NASDAQ: ACET)  
Via Benzinga
Adicet Bio Presents Positive Preclinical Data on ADI-270 at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting
From Adicet Bio, Inc.
Via Business Wire

Performance

YTD
-34.54%
-34.54%
1 Month
-8.18%
-8.18%
3 Month
-29.26%
-29.26%
6 Month
-66.41%
-66.41%
1 Year
-52.54%
-52.54%

More News

Read More
Adicet Bio to Present at the 2023 JMP Securities Life Sciences Conference
From Adicet Bio, Inc.
Via Business Wire
Adicet Reports First Quarter 2023 Financial Results and Provides Business Updates
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
7 Biotech Stocks With Huge Return Potential for Long-Term Investors
Via InvestorPlace
Adicet Bio to Participate in 2023 Canaccord Genuity Horizons in Oncology Virtual Conference
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Adicet Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Company Progress
From Adicet Bio, Inc.
Via Business Wire
7 Biotech Stocks That Could Be the Next Big Thing
Via InvestorPlace
Adicet Bio to Participate in 2023 Jefferies Biotech on the Bay Summit
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Adicet Bio to Participate in a Fireside Chat at the 2023 Guggenheim Oncology Conference
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Peering Into Adicet Bio's Recent Short Interest
Via Benzinga
Dow Surges Over 250 Points; Weber Shares Spike Higher
Via Benzinga
Stocks Hold Gains Ahead Of Tuesday's Economic Flurry
Via Talk Markets
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Crude Oil Rises Sharply; Adicet Bio Shares Plunge
Via Benzinga
RH, HUYA, Bilibili And Some Other Big Stocks Moving Lower On Monday
Via Benzinga
Adicet Bio Shares Fall After Underwhelming Data From Non-Hodgkin's Lymphoma Study
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.